Pfizer (PFE) EBITDA Margin (2009 - 2026)
Pfizer (PFE) posted EBITDA Margin of 42.49% for Q3 2026, down 6.30 percentage points from 48.79% a year earlier but up 3.33 percentage points from the prior quarter.
Powered by 
Analysis
Pfizer (PFE) EBITDA Margin (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 27, 2026, EBITDA Margin at Pfizer was 40.70%, down 2.25 percentage points year-over-year; for FY2025, it came in at 43.66%, up 4.66 percentage points from FY2024.
- Annual EBITDA Margin shows a five-year change of +2.94 percentage points (FY2020 to FY2025).
- In prior years, Pfizer's EBITDA Margin was 39.01% in FY2024 (+18.02 pp), 20.98% in FY2023 (-23.90 pp), 44.89% in FY2022 (+5.78 pp) and 39.11% in FY2021 (-1.61 pp).
- Quarterly EBITDA Margin has run from a low of -8.79% in Q4 2023 to a high of 51.25% in Q2 2022 over five years.
- On a year-over-year basis, EBITDA Margin increased in five of the last eight quarters, with an average year-over-year change of +6.11 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q3 2024, with a gain of 48.12 percentage points; the weakest was Q3 2023, with a drop of 53.38 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was 39.16% (Q2 2026), 48.20% (Q1 2026) and 34.17% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 54.65% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 40.75% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 42.49% |
| 10 | Vertex Pharmaceuticals | 138.78 Bn | 110.77 Bn | 2.91 Bn | 22.73% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 27, 2026 | 42.49% |
| Jun 28, 2026 | 39.16% |
| Mar 29, 2026 | 48.20% |
| Dec 31, 2025 | 34.17% |
| Sep 28, 2025 | 48.79% |
| Jun 29, 2025 | 45.57% |
| Mar 30, 2025 | 47.95% |
| Dec 31, 2024 | 31.45% |
| Sep 29, 2024 | 45.41% |
| Jun 30, 2024 | 30.46% |
| Mar 31, 2024 | 48.03% |
| Dec 31, 2023 | -8.79% |
| Oct 1, 2023 | -2.71% |
| Jul 2, 2023 | 38.32% |
| Apr 2, 2023 | 49.81% |
| Dec 31, 2022 | 31.63% |
| Oct 2, 2022 | 50.68% |
| Jul 3, 2022 | 51.25% |
| Apr 3, 2022 | 45.90% |
| Dec 31, 2021 | 32.52% |
API Access
Pfizer EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PFE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();